Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Y Lau

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 27, 2025
A review to determine regulatorily and reimbursement successes of studies conducted using data from Canadian patient support programs based on the real-world evidence guidelines published by Canadian drug agency and health CanadaCatherine Y Lau
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|February 9, 2024
A big leap in prescription drug promotion in CanadaCatherine Y Lau
Neurosurgery Clinics of North America|March 16, 2015
Quality improvement tools and processesCatherine Y Lau
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|March 20, 2026
Editorial: Volume 2: real world evidence (RWE): paths to enhancing patient access to new medicationsAllison Wills, Catherine Y Lau
Current Oncology (Toronto, Ont.)|September 27, 2024
Is Canada Moving towards a More Agile Regulatory Approval and Reimbursement Process with a Shifting Role for Real-World Evidence (RWE) for Oncology Drugs?Catherine Y Lau, Nigel S B Rawson
Current Oncology (Toronto, Ont.)|April 25, 2025
Accelerating Oncology Drug Reimbursement in Canada: Impact of the CDA-AMC Time-Limited Recommendation and pCPA Temporary Access ProcessCatherine Y Lau, Arif Mitha, Allison Wills
Neurosurgery Clinics of North America|March 16, 2015
Improving patient safety in neurologic surgerySeunggu J Han, John D Rolston, Catherine Y Lau, et al.
Journal of Neurosurgery|December 3, 2013
Changing our culture to advance patient safety: the 2013 AANS Presidential AddressMitchel S Berger, Robert M Wachter, S Ryan Greysen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 29, 2004
Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapyJose Chang, Felix Couture, Scott Young, et al.
BMC Medical Education|July 27, 2025
Bridging early medical education and health systems improvement: a multi-faceted faculty development program to enhance engagement and impactCatherine Y Lau, Edgar Pierluissi, Kristin Casey Callaghan, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 27, 2025
A review to determine regulatorily and reimbursement successes of studies conducted using data from Canadian patient support programs based on the real-world evidence guidelines published by Canadian drug agency and health CanadaCatherine Y Lau
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|February 9, 2024
A big leap in prescription drug promotion in CanadaCatherine Y Lau
Neurosurgery Clinics of North America|March 16, 2015
Quality improvement tools and processesCatherine Y Lau
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|March 20, 2026
Editorial: Volume 2: real world evidence (RWE): paths to enhancing patient access to new medicationsAllison Wills, Catherine Y Lau
Current Oncology (Toronto, Ont.)|September 27, 2024
Is Canada Moving towards a More Agile Regulatory Approval and Reimbursement Process with a Shifting Role for Real-World Evidence (RWE) for Oncology Drugs?Catherine Y Lau, Nigel S B Rawson
Current Oncology (Toronto, Ont.)|April 25, 2025
Accelerating Oncology Drug Reimbursement in Canada: Impact of the CDA-AMC Time-Limited Recommendation and pCPA Temporary Access ProcessCatherine Y Lau, Arif Mitha, Allison Wills
Neurosurgery Clinics of North America|March 16, 2015
Improving patient safety in neurologic surgerySeunggu J Han, John D Rolston, Catherine Y Lau, et al.
Journal of Neurosurgery|December 3, 2013
Changing our culture to advance patient safety: the 2013 AANS Presidential AddressMitchel S Berger, Robert M Wachter, S Ryan Greysen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 29, 2004
Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapyJose Chang, Felix Couture, Scott Young, et al.
BMC Medical Education|July 27, 2025
Bridging early medical education and health systems improvement: a multi-faceted faculty development program to enhance engagement and impactCatherine Y Lau, Edgar Pierluissi, Kristin Casey Callaghan, et al.
Pageof 3